EVERY CURE Trademark

Trademark Overview

On Monday, March 6, 2023, a trademark application was filed for EVERY CURE with the United States Patent and Trademark Office. The USPTO has given the EVERY CURE trademark a serial number of 97824413. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, January 29, 2025. This trademark is owned by EVERY CURE, INC.. The EVERY CURE trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:

(Based on Use in Commerce) Charitable fundraising services

(Based on Intent to Use) Charitable services, namely, promoting public awareness of the need for access to pharmaceuticals; Charitable services, namely promoting public awareness of the need for equitable access to generic drugs for other diseases

(Based on Intent to Use) Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consulting services in the field of pharmaceutical research; Testing of pharmaceuticals; Laboratory research services relating to pharmaceuticals; and using data to identify potential other uses for generic drugs; (Based on Use in Commerce) Charitable services, namely, conducting research, studies and trials for others on alternative uses for pharmaceuticals
every cure

General Information

Serial Number97824413
Word MarkEVERY CURE
Filing DateMonday, March 6, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, January 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2024

Trademark Statements

Goods and Services(Based on Use in Commerce) Charitable fundraising services
Goods and Services(Based on Intent to Use) Charitable services, namely, promoting public awareness of the need for access to pharmaceuticals; Charitable services, namely promoting public awareness of the need for equitable access to generic drugs for other diseases
NOT AVAILABLE"CURE"
Goods and Services(Based on Intent to Use) Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consulting services in the field of pharmaceutical research; Testing of pharmaceuticals; Laboratory research services relating to pharmaceuticals; and using data to identify potential other uses for generic drugs; (Based on Use in Commerce) Charitable services, namely, conducting research, studies and trials for others on alternative uses for pharmaceuticals

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, March 10, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, March 10, 2023
Primary Code036
First Use Anywhere DateWednesday, August 31, 2022
First Use In Commerce DateWednesday, August 31, 2022
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 10, 2023
Primary Code042
First Use Anywhere DateWednesday, August 31, 2022
First Use In Commerce DateWednesday, August 31, 2022

Trademark Owner History

Party NameEVERY CURE, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLA JOLLA, CA 92037
Party NameEVERY CURE, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLA JOLLA, CA 92037

Trademark Events

Event DateEvent Description
Thursday, March 9, 2023NEW APPLICATION ENTERED
Friday, March 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 4, 2023ASSIGNED TO EXAMINER
Tuesday, December 5, 2023NON-FINAL ACTION WRITTEN
Tuesday, December 5, 2023NON-FINAL ACTION E-MAILED
Tuesday, December 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 4, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, March 4, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, May 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 10, 2024NON-FINAL ACTION E-MAILED
Friday, May 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 10, 2024NON-FINAL ACTION WRITTEN
Tuesday, May 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 16, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, May 16, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, May 16, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 16, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 29, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 29, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, January 29, 2025SOU EXTENSION 1 FILED
Wednesday, January 29, 2025SOU EXTENSION 1 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

cure every services pharmaceuticals based research charitable namely drugs other uses field